Byrd Scott A.
Insider CIK 1466916 · CADX SVP, Chief Commercial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 80,000 | $5.45 | $436.0K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 100,000 | $8.60 | $860.0K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 70,314 | $10.49 | $737.6K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 100,000 | $14.00 | $1.40M | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 240,000 | $4.78 | $1.15M | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 8,000 | $4.78 | $38.2K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 125,000 | $3.00 | $375.0K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | U Tender | 2014-03-19 | 2014-03-21 | 2,000 | $14.00 | $28.0K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | A Award deriv | 2014-02-10 | 2014-02-12 | 100,000 | — | $0 | 100,000 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | M Exercise deriv | 2013-12-02 | 2013-12-03 | 7,812 | — | $0 | 70,314 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-12-02 | 2013-12-03 | 7,812 | $9.16 | $71.6K | 2,000 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | M Exercise | 2013-12-02 | 2013-12-03 | 7,812 | $3.51 | $27.4K | 9,812 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | M Exercise deriv | 2013-11-15 | 2013-11-18 | 10,416 | — | $0 | 78,126 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | M Exercise | 2013-11-15 | 2013-11-18 | 10,416 | $3.51 | $36.6K | 12,416 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-11-15 | 2013-11-18 | 10,416 | $8.00 | $83.3K | 2,000 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | M Exercise deriv | 2013-06-07 | 2013-06-11 | 30,657 | — | $0 | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | M Exercise deriv | 2013-06-07 | 2013-06-11 | 36,458 | — | $0 | 88,542 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | M Exercise | 2013-06-07 | 2013-06-11 | 36,458 | $3.51 | $128.0K | 69,115 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-06-07 | 2013-06-11 | 67,115 | $7.53 | $505.4K | 2,000 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | M Exercise | 2013-06-07 | 2013-06-11 | 30,657 | $3.51 | $107.6K | 32,657 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | A Award deriv | 2013-03-13 | 2013-03-15 | 100,000 | — | $0 | 100,000 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | A Award deriv | 2012-03-14 | 2012-03-16 | 30,657 | — | $0 | 30,657 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | A Award deriv | 2012-03-14 | 2012-03-16 | 125,000 | — | $0 | 125,000 | SEC↗ |